VentureSouth is proud to announce a major milestone, as the firm and its investors have now invested in 100 early-stage companies. Earlier this month, VentureSouth invested in Darby, a healthcare technology startup, marking the 100th company in the firm’s portfolio....
If you have ever considered making investments outside of public markets (like stocks and bonds) in alternative investments (like private equity, real estate, startups), you may have been asked if you are an “accredited investor.” So what is an accredited investor and...
If you missed our prior posts in this series on The Case Against Convertible Notes, click to read Part 1 and Part 2 about the downsides for founders and investors. In this third and final post, we’ll reveal some of the hidden costs of convertible notes that are rarely...
If you missed Part 1 of our Case Against Convertible Notes, follow the link to read about the primary downsides for founders. In this post, we’ll tackle our key objections from our point of view as investors. Convertible Note Downsides for InvestorsInadequate...
At VentureSouth, we often find ourselves fielding pitches from entrepreneurs attempting to raise capital via convertible notes. And almost as frequently, we find ourselves pushing back against the convertible note structure in favor of a priced equity round.Since many...
If you’re already familiar with the terms and mechanics associated with convertible notes, skip to Part 1 of our series on The Case Against Convertible Notes. For those of you new to convertible notes, here are the basic terms you’ll want to understand:First,...
In case you missed it, there was big news in the private capital markets last week. No, not just the new direct IPO filings from venture-backed “unicorns” like Palantir and Asana, nor the latest in a string of SPAC announcements - but something more...